Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-25-008214 General Corporate
Debt relative to revenue 0th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
48.38% · OPTIONAL · VALID
Capex intensity 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.14% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-10.17% · OPTIONAL · VALID
Revenue growth 25th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-17.69% · CORE · VALID
Gross margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
74.58% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-3.21% · CORE · VALID
R&D intensity 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.95% · OPTIONAL · VALID
SBC intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.51% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 53.05%
Current 48.38%
Delta -4.67% Capex Intensity Increased
Previous 0.00%
Current 0.14%
Delta 0.14% Cash Generation Decreased
Previous 2.40%
Current -10.17%
Delta -12.57% Growth Increased
Previous -26.88%
Current -17.69%
Delta 9.19% Margin Decreased
Previous 76.23%
Current 74.58%
Delta -1.66% Profitability Increased
Previous -4.43%
Current -3.21%
Delta 1.21% R And D Intensity Increased
Previous 11.65%
Current 11.95%
Delta 0.30% Sbc Intensity Decreased
Previous 4.73%
Current 3.51%
Delta -1.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.